Healthcare and dentistry provider Simplyhealth is accepting a larger stake in OcuPlan, a provider of prognostic and preventative eye care packages.
The investment will expand Simplyhealth’s offering to innovative treatments and funding for diseases affecting seven million people in the UK, such as glaucoma, ocular hypertension, age-related macular degeneration and diabetic retinopathy.
Its technology allows patients to choose their own ophthalmologists and combine them with individual eye care packages, ensuring continuity of treatment and reducing the risk of blindness. It says it will help relieve some of the tension with the NHS.
OcuPlan was founded in 2019 by ophthalmic surgeon Dan Calladin, using technology to make the current treatment of chronic eye problems more accessible and accessible. It employs a network of more than 500 ophthalmologists and ophthalmologists and provides payment plans for those in need of specialized eye care.
The deal marks the first year of Dr. Sne Hemka’s tenure as CEO of Simplyhealth.
“As a former ophthalmic surgeon, I know that OcuPlan technology can enable people with long-term eye disease to control their treatment and their health,” he said.
“It can also really help take the burden off the NHS, and I couldn’t be proud of what made OcuPlan our first investment as CEO.”
Colladin added: “Simplyhealth shares our belief in the value of preventive care; Joining its ecosystem means we can expand our offering to more people with long-term eye problems who want to see their chosen professional in an accessible way.
“Simplyhealth is the future of healthcare, we are excited to be a part of it.”